Abbott Receives FDA Approval For TRILIPIX?, First And Only Fibrate Indicated For Use In Combination With A Statin For Cholesterol Management

Recently, the U.S. Food and Drug Administration (FDA) approved Abbott’s TRILIPIX? (fenofibric acid) delayed-release capsules for use along with diet to help lower triglycerides and LDL cholesterol, and to raise HDL cholesterol in patients with lipid problems. TRILIPIX is the first and only fibrate to be approved for use in combination with a statin. In certain patients, treatment guidelines recommend the combination of a fibrate with a statin to further improve lipid levels.

More: continued here

Filed under: Cholesterol on January 3rd, 2009